Evidence map›Paper›PMID 41904557›Full record

ArticleImplementation science : IS2026

Study protocol for coaching and leadership in autism support settings: a cluster randomized controlled hybrid type 2 effectiveness-implementation trial.

Jill Locke, Nathaniel J Williams, Aksheya Sridhar, Wendy Shih, Christine Espeland, Daina Tagavi, Karen Bearss

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Implementation science : IS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07276750 (Coaching and Leadership in Autism Support Settings), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07276750 narecruitingnot on this map

Coaching and Leadership in Autism Support Settings

TypeinterventionalSponsorUniversity of California, Los AngelesRan2026 to 2030Enrolled373ConditionsAutism Spectrum Disorder (ASD)ArmsRUBIES, HELM, Educator Psychoeducation
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jill LockeUniversity of California, Los Angeles, 457 Portola Plaza, Los Angeles, CA, 90095, USA. locke@seis.ucla.edu.
Nathaniel J WilliamsBoise State University, 1910 W. University Dr., Boise, ID, 83725, USA.
Aksheya SridharUniversity of Washington, Seattle, WA, 98115, USA.
Wendy ShihUniversity of California, Los Angeles, 457 Portola Plaza, Los Angeles, CA, 90095, USA.
Christine EspelandUniversity of Washington, Seattle, WA, 98115, USA.
Daina TagaviUniversity of Washington, Seattle, WA, 98115, USA.
Karen Bearss, Catalight, Walnut Creek, CA, USA.

Funding

Coaching and Leadership in Autism Support Settings (CLASS)R01MH135924 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KAREN ELIZABETH BEARSS, JILL J LOCKE · 2025 to 2026
$1.9M
NIMH NIH HHS R01 MH135924
6 · The paper itself

Abstract

backgroundThe increased prevalence of autism spectrum disorder creates a sense of urgency to improve outcomes for this population in publicly funded education systems, the primary setting in which autistic children receive behavioral health services in the United States. Important barriers to progress include a lack of feasible clinical interventions that address autistic children's externalizing behaviors in schools and major challenges sustaining fidelity to newly implemented programs over time. This trial addresses these gaps by (1) testing the clinical effectiveness of the Research Units on Behavioral Interventions in Educational Settings (RUBIES) program relative to educator psychoeducation on externalizing behaviors of autistic children in public elementary schools, and (2) testing the effects of adding a leadership-focused organizational implementation strategy, Helping Educational Leaders Mobilize Evidence (HELM), to educator coaching in RUBIES on RUBIES sustainment.

methodsIn a cluster-randomized, hybrid type 2 effectiveness-implementation trial, schools will be randomized to one of 3 arms: 1) educator coaching in RUBIES and school participation in HELM; 2) educator coaching in RUBIES only; or 3) a control condition incorporating an active clinical comparator, educator psychoeducation. We will enroll 42 schools and 126 educators yoked to 126 elementary-aged autistic children. Depending on arm, educators will complete study instruments up to six times: 1) Spring semester prior to the year of school and student enrollment (implementation baseline; arms 1-2); 2) Fall semester Year 1 (clinical baseline; arms 1-3); 3) 16 weeks (arms 1-3); 4) 24 weeks (arms 1-3); 5) 52 weeks (arms 1-2); and 6) 76 weeks (arms 1-2). The primary clinical outcome compares arms 1 & 2 vs. 3 on change in autistic children's externalizing behavior from clinical baseline to 24 weeks. The primary implementation outcome compares arms 1 vs. 2 on RUBIES sustainment, operationalized as educators' average RUBIES fidelity at 52 and 76 weeks. DISCUSSION: Generating evidence for the clinical effectiveness of RUBIES addresses a significant gap in educator-delivered interventions to minimize highly prevalent externalizing behaviors among autistic children in public schools. Simultaneously, testing the effectiveness of HELM on sustainment of RUBIES will inform future efforts to successfully implement and sustain new innovations for autistic youth in public schools. NAME OF THE REGISTRY: Clinical Trials.

trial registrationNCT07276750. Date of registration 12/10/25. URL of trial registry record https://clinicaltrials.gov/study/NCT07276750?cond=Autism&intr=RUBIES&rank=1 .

Indexed as

Autism Spectrum DisorderAutistic DisorderBehavior TherapyLeadershipMentoringChildHumansImplementation ScienceRandomized Controlled Trials as TopicSchoolsAutismEducator coachingExternalizing behaviorImplementation climateImplementation leadershipImplementation strategySchools

Identifiers

PMID41904557
PMCPMC13151114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.